Ireland's most popular source of accurate and reliable medicines information
Search 2626 medicines for SPCs, PILs and Educational Materials
COVID-19 Vaccine Information
Latest medicine updates
- Herzuma 150 mg and 420 mg powder for concentrate for solution for infusion Mundipharma Pharmaceuticals Limited - Formerly Napp Laboratories
- INNOVACE TABLETS Organon Pharma (Ireland) Limited
- Cosentyx 300mg solution for injection in pre-filled pen Novartis Ireland Limited
- Amisulpride 50mg & 200mg Tablets Gerard Laboratories
- Ultomiris 1100mg/11ml Alexion Pharma UK Ltd
- Ultomiris 300mg/3ml Alexion Pharma UK Ltd
- Celebrex 200 mg capsule, hard Pfizer Healthcare Ireland
Medicines.ie contains accurate, up to date, regulator approved information on medicines available in Ireland. The site is designed to be a comprehensive and easily searchable source of medicines information in Ireland.
It is widely regarded as an invaluable reference source by healthcare professionals, the National Medicines Information Center and the Department of Health.
The information for each product comes in the form of a Summary of Product Characteristics (SPC or SmPC) and Patient Information Leaflet (PIL) or Package Leaflet (PL), where relevant. These documents are approved by the medicines’ regulator (HPRA or EMA) as part of the process of authorising a medicine for sale or supply in Ireland.
Medicines.ie is continuously updated by pharmaceutical companies when new medicines are launched or the information for an existing medicine changes.
For information on types of documents on www.medicines.ie, please see below.
Summary of Product Characteristics
Summaries of product characteristics form the basis of information for healthcare professionals on how to use the medicine safely and effectively. Abbreviated as SPC.
Patient Information Leaflet
A PIL is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the SPC.
EDMs are additional risk minimisation measures that are intended to promote the safe and effective use of the medicine. Educational materials focus on one or more specific safety concerns related to use of the medicine.
Some pharmaceutical companies have chosen to display PIL in a HTML text only “Print View” version, called an XPIL, as well as in PDF format. The XPIL is designed for people with sight challenges.